Recently, the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy (cIMPACT-NOW) recommended that GBM with IDH mutations should be referred to as IDH-mutant astrocytoma and excluded from GBM diagnosis (2). The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).